At 16.8x earnings and 13.5x forward earnings, DLTR trades at a multiple that implies moderate growth without speculative excess, especially with a PEG of 1.4 suggesting growth is not egregiously overpriced. The Altman Z-Score of 3.50 places the company firmly in the safe zone, signaling low bankruptcy risk despite leverage. A Piotroski F-Score of 8 reinforces strong fundamental quality, while a 1.1 Price/Sales ratio keeps valuation grounded relative to revenue scale. However, the sharp drop from $11.00 EPS to an estimated $5.95 next year introduces earnings compression risk that the market may not be fully discounting. Overall, this looks like a fundamentally stable company priced as a steady grower, not a distressed asset—mispricing, if any, lies in whether earnings normalization proves temporary.